APA (7th ed.) Citation

Rossignol, P., Lainscak, M., Crespo‐Leiro, M. G., Laroche, C., Piepoli, M. F., Filippatos, G., . . . Branko Beleslin, R. (2020). Unravelling the interplay between hyperkalaemia, renin-angiotensin-aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry. European Journal of Heart Failure, 22(8), 1378. https://doi.org/10.1002/ejhf.1793

Chicago Style (17th ed.) Citation

Rossignol, Patrick, et al. "Unravelling the Interplay Between Hyperkalaemia, Renin-angiotensin-aldosterone Inhibitor Use and Clinical Outcomes. Data from 9222 Chronic Heart Failure Patients of the ESC-HFA-EORP Heart Failure Long-Term Registry." European Journal of Heart Failure 22, no. 8 (2020): 1378. https://doi.org/10.1002/ejhf.1793.

MLA (9th ed.) Citation

Rossignol, Patrick, et al. "Unravelling the Interplay Between Hyperkalaemia, Renin-angiotensin-aldosterone Inhibitor Use and Clinical Outcomes. Data from 9222 Chronic Heart Failure Patients of the ESC-HFA-EORP Heart Failure Long-Term Registry." European Journal of Heart Failure, vol. 22, no. 8, 2020, p. 1378, https://doi.org/10.1002/ejhf.1793.